Keyphrases
Allelic Imbalance
13%
Autoimmune Lymphoproliferative Syndrome
5%
BRCAness
5%
Chemotherapy
13%
Childhood Cancer
9%
Clinical Characteristics
6%
Clinical Course
5%
Constitutional Mismatch Repair Deficiency (CMMRD)
8%
Copy number Variation
5%
Doxorubicin
5%
Etoposide
6%
Event-free Survival
6%
Ewing Sarcoma Family of Tumors
5%
Favorable Outcome
6%
Gene Expression
7%
Gene Signature
5%
Genetic Modification
13%
Genomic Instability
6%
Germ Cells
10%
Germany
7%
High Risk
7%
High-grade Osteosarcoma
9%
Immune Thrombocytopenia
5%
Loss of Heterozygosity
7%
Lymphoproliferative Disorders
5%
Malignancy
6%
Metastasis
9%
MicroRNA
9%
Microsatellite Instability-high (MSI-H)
8%
MiR-17-92 Cluster
5%
Multiple Myeloma
5%
Oncogene
6%
Osteosarcoma
100%
Osteosarcoma Cell Lines
6%
Osteosarcoma Cells
9%
Overexpression
7%
Pediatric
12%
Pediatric Cancer Patients
6%
Pediatric Oncology
9%
Precision Oncology
5%
Prognostic Factors
6%
Radiation Effects
6%
Randomized Controlled Trial
5%
Response to Chemotherapy
5%
Rhabdomyosarcoma
7%
Targeted Therapy
5%
Tumor
34%
Tumor Protein p53 (TP53)
8%
Tumor Suppressor Gene
6%
Whole-body MRI
5%
Medicine and Dentistry
Adolescence
5%
Cancer
6%
Cancer Susceptibility
6%
Chemotherapy
17%
Childhood Cancer
13%
Diagnosis
5%
Disease
16%
Epstein Barr Virus
6%
Etoposide
6%
Event Free Survival
5%
Ganglioneuroblastoma
8%
Metastatic Carcinoma
12%
Neoplasm
33%
Oncology
7%
Osteosarcoma
48%
Pediatric Cancer
7%
Pediatrics
20%
Personalized Medicine
5%
Programmed Cell Death
5%
Progression Free Survival
5%
Randomized Controlled Trial
5%
Receptor
5%
Recurrent Disease
9%
Rhabdomyosarcoma
5%
Surgery
5%
T Cell
9%
Targeted Therapy
8%
Biochemistry, Genetics and Molecular Biology
Adolescence
5%
Allele
5%
Allelic Imbalance
14%
Alpha Radiation
5%
Carcinogenesis
7%
Chromothripsis
5%
DNA Mismatch Repair
9%
Ewing Sarcoma
5%
Gene Expression Profiling
7%
Gene Mutation
12%
Genetics
17%
Genome Instability
9%
Genomics
18%
Genotyping
6%
Germ Cell
14%
Germline
14%
Karyotype
7%
Long Term Survival
7%
Loss of Heterozygosity
8%
Messenger RNA
6%
MicroRNA
11%
Microsatellite Instability
8%
Myeloid
5%
Oncogene
6%
P53
7%
Promoter Region
8%
Signal Transduction
6%
Single-Nucleotide Polymorphism
8%
Transcription Factors
7%
Tumor Suppressor Gene
6%
